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Abstract
C. elegans is widely used to investigate biological processes related to health and disease. To study 
protein localization, fluorescently-tagged proteins can be used in vivo or immunohistochemistry 
can be performed in whole worms. Here, we describe a technique to localize a protein of interest 
at a subcellular level in C. elegans lysates, which can give insight into the location, function and/or 
toxicity of proteins.
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Background
Subcellular fractionation has been used in different model organisms to identify and study 
protein function in nuclei, membranes and cytoplasm. For example, aggregation-prone 
proteins may be more toxic when they are localized in the nucleus or in the cytosol 
(Kontopoulos et al., 2006; Barmada et al., 2010). Here we provide a protocol (adapted from 
Chen et al., 2000 and La Rocca et al., 2007) to localize specific proteins in the nuclear and 
cytoplasmic fractions of C. elegans.
Materials and Reagents
1. 94 mm plates (Greiner Bio One International, catalog number: 633185)
2. 15 ml conical tube (SARSTEDT, catalog number: 62.554.502)
3. 1.5 ml tubes (Greiner Bio One International, catalog number: 616201)
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4. Pellet pestle (Sigma-Aldrich, catalog number: Z359947-100EA)
5. Glass slides (Fisher Scientific, catalog number: 12164682)
6. Nitrocellulose (Bio-Rad Laboratories, catalog number: 1620112)
7. C. elegans strain
8. Escherichia coli OP50 strain
9. Deionized water (dH2O)
10. Cholesterol (Fisher Scientific, catalog number: 10263660)
11. Ethanol absolute (Merck, catalog number: 1009831000)
12. Magnesium sulphate (MgSO4) (Fisher Scientific, catalog number: 10264630)
13. Calcium dichloride (CaCl2) (Fisher Scientific, catalog number: 10171800)
14. di-Potassium hydrogen phosphate (K2HPO4) (Merck, catalog number: 105101)
15. Potassium dihydrogen phosphate (KH2PO4) (Merck, catalog number: 104873)
16. Casein digest, Difco (BD, catalog number: 211610)
17. Select agar (Thermo Fisher Scientific, Invitrogen™, catalog number: 30391049)
18. Disodium hydrogen phosphate (Na2HPO4) (Acros Organics, catalog number: 
424380010)
19. Sodium chloride (NaCl) (Merck, catalog number: 106404)
20. DL-Dithiothreitol (DTT) (Sigma-Aldrich, catalog number: D0632)
21. HEPES (Sigma-Aldrich, catalog number: H4034)
22. Potassium hydroxide (KOH) (Fisher, catalog number: 10705921)
23. Potassium chloride (KCl) (Fisher Scientific, catalog number: 10010310)
24. Magnesium dichloride (MgCl2) (Fisher Scientific, catalog number: 10518060)
25. Ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich, catalog number: 
E6758)
26. Sucrose (Fisher Scientific, catalog number: 10386100)
27. Tween 20 (Sigma-Aldrich, catalog number: P1379-100ML)
28. Protease inhibitors (cOmplete) (Roche, catalog number: 11697498001)
29. Benzonase nuclease (Merck, catalog number: 70746)
30. Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific, catalog number: 
23225)
31. Liquid nitrogen
32. Ammonium persulfate (APS) (Thermo Fisher Scientific, catalog number: A/
6120/60)
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33. N,N,N′,N′-Tetramethylethylenediamine (TEMED) (Fisher Scientific, catalog 
number: 10142863)
34. 40% Acrylamide/Bis solution (29:1) (Bio-Rad Laboratories, catalog number: 
1610146)
35. Sodium dodecyl sulfate (SDS) (Merck, Calbiochem, catalog number: 428015)
36. Tris Base (Roche Diagnostics, catalog number: 11814273001)
37. Hydrochloric acid 37% (Acros Organics, catalog number: 124630010)
38. Glycine (Fisher Scientific, catalog number: 10070150)
39. Methanol (Merck, catalog number: 106009)
40. Bromophenol blue (Acros Organics, catalog number: 403160100)
41. Glycerol (Sigma-Aldrich, catalog number: G5516)
42. β-Mercaptoethanol (Merck, catalog number: 444203)
43. Milk powder (Campina)
44. PageRuler™ Plus Prestained Protein Ladder (Thermo Fisher Scientific, catalog 
number: 26619)
45. Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare, 
catalog number: RPN2236)
46. Antibodies (see Table 1)
47. M9 buffer (see Recipes)
48. Phosphate buffered saline (PBS) (see Recipes)
49. PBS-T (see Recipes)
50. Blocking solution (see Recipes)
51. Nematode growth medium (NGM) plates (see Recipes)
52. Phosphate buffer (see Recipes)
53. Hypotonic buffer (see Recipes)
54. Hypertonic buffer (see Recipes)
55. 25x protease inhibitors (see Recipes)
56. 1 M DTT (see Recipes)
57. 12% acrylamide gel (see Recipes)
58. Running buffer (see Recipes)
59. Transfer buffer (see Recipes)
60. SDS lysis buffer (see Recipes)
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Equipment
1. Single channel pipettes (Gilson, models: P2G, P20G, P200G, P1000G)
2. Orbital shaker (Thermo Fisher Scientific, model: MaxQ™ 2000)
3. 20 °C incubator (Winecooler, LIEBHERR, model: WK 4126)
4. Stereo microscope (Leica, model: MZ7.5)
5. Pellet pestle (motor) (Sigma-Aldrich, catalog number: Z359971)
6. Tabletop centrifuge, cooled (Eppendorf, model: 5424 R)
7. Centrifuge (Thermo Fisher Scientific, model: SL 40R)
8. Autoclave (VWR, model: VAPOUR-Line Lite)
9. -80 °C freezer (Sanyo, model: VIP plus)
10. Mini PROTEAN 3 system (Bio-Rad Laboratories, catalog number: 1658001edu)
11. WB Imager (GE Healthcare, model: ImageQuant LAS 4000 mini, catalog 
number: 28955813)
Software
1. ImageJ (Open source: https://imagej.nih.gov/ij/)
2. Microsoft Excel (Microsoft Corporation, Redmond, USA)
Procedure
A. Collection of worms
1. Prepare 10-15 plates of bleach synchronized worms, with 
approximately 800-1,000 worms per 9 cm NGM plate in order to get 
relatively large nuclear fractions.
Note: We performed subcellular fractionation experiments with as few 
as 5 x 9 cm NGM plates per condition. However, working with 10 x 9 
cm NGM plates will yield a more workable nuclear fraction, as the 
pellet will be more easily visible during the washing steps.
2. Incubate worms at 20 °C for approximately 72 h, until day 1 of 
adulthood (D1).
Note: Subcellular fractionation can be performed at different ages of 
worms. Here, we describe a protocol for worms at the first day of 
adulthood (D1). However, the protocol is also feasible for L4-staged 
animals and older worms. One should keep in mind that it is easier to 
break the cuticle of larvae with a pellet pestle than older worms. Thus, 
the number of strokes should be adjusted accordingly to the age of the 
worms (7-12 times).
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3. Collect D1-staged worms with ~4 ml M9 per plate in a 15 ml conical 
tube and wash until the supernatant is clear (3-5 times).
4. Wash the worm pellet twice with 1 ml cold hypotonic buffer.
5. Prepare 2-5 ml ‘complete hypotonic buffer’ per sample by adding 1 M 
DTT (final concentration: 1 mM DTT) and 25x protease inhibitors 
(final concentration: 2x protease inhibitors) to a few ml of standard 
hypotonic buffer.
Note: It is suggested to calculate the volume of ‘complete hypotonic 
buffer’ that is required for the experiment. Pipette the required volume 
of hypotonic buffer in a tube and add DTT and protease inhibitors; 
compounds that should both be stored at -20 °C.
6. Remove all hypotonic buffer and add ‘complete hypotonic buffer’, as 
prepared in Step A5 (~500 μl). Transfer the worm suspension into a 1.5 
ml tube.
Note: Estimate the volume of the worm pellet and add the same volume 
of ‘complete hypotonic buffer’.
7. Avoid freezing the worm pellet at this point, as this may damage the 
nuclei and cause leakage of nuclear proteins in the cytosol.
B. Fractionation
1. Homogenize worms with a pellet pestle for 1 min and let the worms rest 
for 1 min, repeat this 5 to 10 times. Keep the worms on ice during the 
whole process. Pipette 5 μl of the worm suspension onto a glass slide 
after 4-5 times grinding the pellet with the pestle to evaluate the degree 
of worm lysis. Homogenization is complete when 70%-80% of the 
worms are disrupted and only a few worm remnants are visible (see 
Figure 1).
2. Pellet the worm bodies and debris by spinning at 500 x g, 4 °C for 5 
min.
3. Transfer the supernatant to a new 1.5 ml tube and spin again at 500 x g, 
4 °C for 5 min to make sure you get rid of all the worm debris.
4. Transfer the supernatant to a new 1.5 ml tube. Save 25-30 μl of this 
fraction in a new 1.5 ml tube (‘input fraction’) and keep on ice. Write 
down the total volume of supernatant. Discard the pellet.
5. Pellet the nuclei at 4,000 x g, 4 °C for 5 min.
6. Transfer the supernatant to a new 1.5 ml tube and centrifuge at maximal 
speed (17,000 x g), 4 °C for 30 min. Transfer the supernatant to a new 
1.5 ml tube; this will contain the ‘cytoplasmic fraction’.
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7. Wash the pellet from Step B5 with 500 μl ‘complete hypotonic buffer’ 
(as prepared in Step A5) and centrifuge the samples at 4,000 x g, 4 °C 
for 5 min.
8. Discard the supernatant and add 500 μl of fresh ‘complete hypotonic 
buffer’ (as prepared in Step A5) to resuspend the nuclear pellet and 
pipette the suspension into a new 1.5 ml tube. Centrifuge the samples at 
4,000 x g, 4 °C for 5 min.
Note: It is important to change tubes after each wash, as tubulin and 
fatty substances tend to stick to the tube walls, which may contaminate 
the nuclear fraction.
9. Prepare ‘complete hypertonic buffer’ by adding 1 M DTT (final 
concentration: 1 mM DTT) and 25x protease inhibitors (final 
concentration: 2x protease inhibitor) to the hypertonic buffer.
10. Remove the supernatant and dissolve the pellet in a small volume of 
‘complete hypertonic buffer’ (as prepared in Step B9) (half of or less 
the volume that was noted in Step B4). Write down the volume that was 
used to dissolve the nuclear fraction. Transfer the suspension to a new 
1.5 ml tube; this will contain the ‘nuclear fraction’.
11. OPTIONAL: For better protein extraction add 25 U/μl of Benzonase 
nuclease to the ‘nuclear fraction’ and incubate the sample at 4 °C for 45 
min on an orbital shaker.
12. Determine at this point the protein concentration of the ‘input’ (~20 μg/
μl), ‘cytosolic fraction’ (~18 μg/μl) and ‘nuclear fraction’ (~5 μg/μl) 
with the Pierce™ BCA Protein Assay Kit.
13. Safe stopping point: Flash freeze samples in liquid nitrogen and store at 
-80 °C until further use (see Figure 2 for a schematic overview of the 
fractionation steps).
C. Western blotting
1. Thaw the samples containing the ‘input’, ‘cytosolic fraction’ and 
‘nuclear fraction’. Pipette a volume of the samples (either the same 
amount of protein for all fractions or the same volume) into new 1.5 ml 
tubes.
Note: When equal volumes are loaded, one can actually compare the 
amount of specific protein between the different fractions within a 
sample. When equal protein amounts are loaded, one can look for an 
enrichment of a protein within specific fractions between conditions or 
worm strains. Importantly, always write down the volume of the total 
input fraction and the volume in which the nuclear fraction is dissolved. 
Enriching the nuclear fraction, i.e., dissolving the pellet in less volume, 
increases the concentration of proteins, which may be useful during 
immunoblotting. However, in this situation the signal cannot be 
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compared directly to that of the input, as this fraction is not enriched in 
the same way. Therefore, corrections based on the described volumes 
should be performed afterward.
2. Add ¼ volume of SDS lysis buffer (5x).
3. Boil the samples at 95 °C for 10 min.
4. Prepare a 12% SDS polyacrylamide gel.
5. Load the samples and the protein marker onto the 12% SDS 
polyacrylamide gel. Fill the tank with running buffer and start run at 
100 V until the samples have run through the stacking gel and then 
continue at 120-140 V until the dye front reaches the bottom of the gel.
6. Blot the gel to a nitrocellulose membrane with a wet transfer in the 
transfer buffer at 95 V for 55-60 min at 4 °C.
7. Block the nitrocellulose membrane for 1 h in blocking solution.
OPTIONAL: Cut the nitrocellulose membrane just below the 70 kDa 
marker (LMN-1 normally runs around 70 kDa and tubulin around 55 
kDa). But keep in mind the size of your protein of interest.
8. Incubate the membrane with the appropriate antibodies for 1 h at room 
temperature or overnight at 4 °C (see Table 1). LMN-1 is used as a 
nuclear marker (~70 kDa) and tubulin (~55 kDa) as a cytosolic marker.
9. Wash the membranes 3 x 10 min with 1x PBS-T.
10. Incubate the membranes with the appropriate HRP-conjugated 
secondary antibodies for 1 h at room temperature (see Table 1).
11. Wash the membranes 3 x 10 min with 1x PBS-T.
12. Add the ECL to the membranes and develop the blots with the Las 4000 
mini.
OPTIONAL: When not cutting the membranes, one can strip the 
membranes and re-probe with a different antibody of interest.
Data analysis
Figure 3 shows an example of an immunoblot. At least three independent experiments 
should be performed and an example of data analysis can be found in Figures 5 and S5C of 
Sin et al. (2017)s. The fraction levels were quantified by densitometry using ImageJ. A 
detailed tutorial is available at https://imagej.nih.gov/ij/docs/menus/analyze.html (under 
“Gels Submenu”) and at http://lukemiller.org/index.php/2010/11/analyzing-gels-and-
western-blots-with-image-j/.
To calculate the cytosol/input ratio, the signal of interest can be normalized against the 
signal of the cytosolic marker (α-tubulin). The nuclear fraction is a concentrated sample, and 
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therefore one should use the input volume and the volume in which the nuclear fraction was 
resuspended to calculate the “real” value.
Recipes
1. M9 buffer (1 L)
KH2PO4 3 g
Na2HPO4 6 g
NaCl 5 g
dH2O 1,000 ml
Autoclave at 121 °C for 20 min
1 M MgSO4 1 ml (add after autoclaving)
2. PBS (1 L)
NaCl 8 g
KCl 0.2 g
KH2PO4 0.24 g
Na2HPO4 1.44 g
dH2O 1,000 ml
HCl Adjust pH to 7.2-7.6
Autoclave at 121 °C for 20 min
3. PBS-T
PBS containing 0.01% Tween 20
4. Blocking solution
5% Milk in PBS-T
5. NGM plates (1 L)
NaCl 3 g
Select Agar 17.5 g
Casein digest 7.5 g
Autoclave at 121 °C for 20 min and then cool to ~55 °C
After cooling add the following buffers:
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1 M MgSO4 1 ml
1 M CaCl2 1 ml
Cholesterol (5 mg/ml in ethanol) 1 ml
1 M Phosphate buffer 25 ml
6. Phosphate buffer 1 M pH 6.0 (1 L)
KH2PO4 118 g
K2HPO4 23 g
Autoclave at 121 °C for 20 min
7. Hypotonic buffer
HEPES KOH pH 7.6 15 mM
KCl 10 mM
MgCl2 5 mM
EDTA 0.1 mM
Sucrose 350 mM
8. Hypertonic buffer
HEPES KOH pH 7.6 15 mM
KCl 400 mM
MgCl2 5 mM
EDTA 0.1 mM
Tween 20 0.1%
Glycerol 10%
9. 25x protease inhibitors
Dissolve 1 tablet Complete in 2 ml dH2O (store at -20 °C)
10. 1 M DTT
Dissolve 0.154 g DTT in 1 ml dH2O (store at -20 °C)
11. 12% acrylamide gel (1.0 mm cassette)
Running Gel Stacking Gel
dH2O 2.2 ml 1.74 ml
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Tris-HCl (1.5 M, pH 8.8) 1.25 ml
Tris-HCl (0.5 M, pH 6.8) 0.625 ml
40% acrylamide/bis (29:1) 1.5 ml 0.25 ml
10% SDS 50 μl 25 μl
10% APS 25 μl 25 μl
TEMED 2.5 μl 2.5 μl
12. Running/transfer buffer
Running buffer Transfer buffer
Tris-HCl 0.025 M 0.025 M
Glycine 0.192 M 0.192 M
SDS 0.1%
Methanol 10%
13. SDS lysis buffer(5x)
Tris-HCl (1 M, pH 6.8) 250 mM
SDS 8%
Bromphenol blue 0.1%
Glycerol (80%, v/v) 40%
β-mercaptoethanol 7 μl/ml
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Figure 1. Example of worm homogenization.
A. Incomplete homogenization. B. Complete homogenization.
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Figure 2. Schematic overview of the fractionation protocol
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Figure 3. Subcellular fractionation of wild type (N2) worms and worms expressing 40 
polyglutamine repeats fused to YFP (Q40-YFP, AM141).
A representative immunoblot was probed with α-GFP antibody to detect polyglutamine. 
LMN-1 (nuclear marker) and α-tubulin (cytosolic marker) were used as controls. More 
details of the experiment can be found in Sin et al. (2017).
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Table 1
List of primary and secondary antibodies
Primary antibody Host Company/Catalog number Dilution primary antibody Secondary antibody
α-LMN-1 Rabbit Novus Biologicals, catalog 
number: 38530002 1:1,000
Anti-rabbit (1:10,000) (Bio-Rad 
Laboratories, catalog number: 
1706515)
α-tubulin Mouse Sigma-Aldrich, catalog number: T6074 1:10,000
Anti-Mouse (1:10,000) (Bio-Rad 
Laboratories, catalog number: 
1706516)
α-GFP (Living Colors® 
A.v. Monoclonal 
Antibody (JL-8)
Mouse Takara Bio, catalog number: 632381 1:10,000
Anti-Mouse (1:10,000) (Bio-Rad 
Laboratories, catalog number: 
1706516)
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